Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Instituto do Cancer do Estado de São Paulo
West China Hospital
Fudan University
Rutgers, The State University of New Jersey
Sun Yat-sen University
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University Health Network, Toronto
Mayo Clinic
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Fudan University
Hospital Israelita Albert Einstein
UNICANCER
MedSIR
Sun Yat-sen University
UNICANCER
Fudan University
M.D. Anderson Cancer Center
Latin American Cooperative Oncology Group
UNICANCER
The Netherlands Cancer Institute
Centre Hospitalier Universitaire de Besancon
National Institutes of Health Clinical Center (CC)
University Hospitals Bristol and Weston NHS Foundation Trust
University of Alabama at Birmingham
Sun Yat-sen University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
AIDS Malignancy Consortium
Institute of Cancer Research, United Kingdom
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
Hoag Memorial Hospital Presbyterian